|Generic name||Deferoxamine mesylate|
|Brand name(s), other common name(s)||Desferal®, DFO|
|Drug type||Iron chelator|
|How the drug is given||Intramuscular (IM) or subcutaneous (SC) injection; may be given intravenously (IV)|
Indications and Usage
Deferoxamine mesylate is FDA approved to treat people who have acute iron intoxication and of chronic iron overload due to transfusion-dependent anemia.
Side effects needing medical attention
Hearing loss; vision problems; decrease in urination; fever; unusual bleeding or bruising; lack of energy; loss of appetite; pain in the upper right part of the stomach; yellowing of the skin or eyes; hives; rash; difficulty breathing or swallowing; swelling of the face, throat, tongue, lips, eyes, hands, feet or ankles.